Passport Health, an immunization and travel health center with national headquarters in Baltimore, reports that its participation in vaccine trials will expand this year with several new clinical trials in the pipeline. "We're helping pharmaceutical companies and the FDA bring vaccines to market because this cannot be done without successful clinical trials and proper recruitment of patients," says Fran Lessans, RN, MS, Founder & CEO of Passport Health, which is the largest private purchaser of vaccinations in the U.S. Yahoo News (http://biz.yahoo.com/prnews/060613/phtu016.html?.v=62)
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
FDA Extends UDI Deadlines Another Two Years for Class I, Unclassified Devices
The FDA said the new compliance date is Sept. 24, 2020.
United Exchange Warned for Inaccurate Listing Information
The agency had previously pointed out the deficiency in a February letter to the company.
